|
IPMK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.765800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.416500E-03 |
| Normal-vs-Stage2 |
4.203400E-01 |
| Normal-vs-Stage3 |
8.494600E-01 |
| Normal-vs-Stage4 |
6.031000E-01 |
| Stage1-vs-Stage2 |
2.158200E-01 |
| Stage1-vs-Stage3 |
1.576210E-01 |
| Stage1-vs-Stage4 |
4.161400E-01 |
| Stage2-vs-Stage3 |
5.428800E-01 |
| Stage2-vs-Stage4 |
9.430400E-01 |
| Stage3-vs-Stage4 |
6.571000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.665900E-02 |
| Normal-vs-AfricanAmerican |
5.068500E-02 |
| Normal-vs-Asian |
4.256100E-02 |
| Caucasian-vs-AfricanAmerican |
8.830400E-01 |
| Caucasian-vs-Asian |
5.337600E-01 |
| AfricanAmerican-vs-Asian |
5.245200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.304570E-03 |
| Normal-vs-Female |
6.202800E-01 |
| Male-vs-Female |
3.979600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.379600E-02 |
| Normal-vs-Extreme_Weight |
5.98269999999568E-05 |
| Normal-vs-Obese |
6.424000E-01 |
| Normal-vs-Extreme_Obese |
3.834400E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.601650E-01 |
| Normal_Weight-vs-Obese |
2.946400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.308600E-01 |
| Extreme_Weight-vs-Obese |
8.357800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.556400E-01 |
| Obese-vs-Extreme_Obese |
1.533990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.165400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.379400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.456000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.427900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.919400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.324600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.061200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.400300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.236100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.127900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.404830E-03 |
| Normal-VS-Type2 PRCC |
1.575570E-01 |
| Normal-VS-KIRP CIMP |
1.483550E-01 |
| Normal-VS-Unclassified PRCC |
7.290200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.957600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.631700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.375500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.708300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.549840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.744630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.064200E-02 |
| Normal-vs-N1 |
3.988600E-01 |
| Normal-vs-N2 |
9.522200E-01 |
| N0-vs-N1 |
8.837600E-02 |
| N0-vs-N2 |
4.239600E-01 |
| N1-vs-N2 |
7.029800E-01 |
|
|
